본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

R&D Fields

Print

BGMs Development

Despite advancements in modern medicine, the number of patients suffering from diabetes and metabolic diseases continues to rise globally. These conditions require not only treatment but also long-term and systematic management. The GCMS BGMs Development Team is dedicated to addressing these global health challenges by researching and developing various electrochemical-based sensors, including blood glucose sensors, ketone sensors, uric acid sensors, and lactate sensors. We are constantly advancing sensor technologies to ensure accuracy and reliability, striving to establish a new paradigm for managing diabetes and metabolic diseases.
We remain committed to improving the quality of life for patients and leading innovation in the diagnostic field through continuous efforts and challenges.